Trial intelligence / Profile preview

N-acetylcysteine in Rheumatoid Arthritis

IRCT20190626044030N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of acetylcysteine in rheumatoid arthritis (RA), sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2019; status: completed.

02

Drugs

acetylcysteine
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on IRCT20190626044030N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190626044030N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call